ALFA Finder| Revenue growth | Flat YoY at ₹4300cr for FY26. |
|---|---|
| Margins | Structural margins improved by 100bps; net margin up ~200bps over 10Y. |
| Demand visibility | Muted sales; rural consumption softening due to inflation. |
| Management confidence | High; focusing on long-term value via Integrated Growth Strategy. |
Growth
PAT grew 19% YoY to ₹850cr; sales flat at ₹4300cr. 10-year CAGR: sales doubled, profit doubled.
Outlook
Targeting mid-to-high single-digit category growth. Multi-year productivity program delivered ₹86cr savings in FY26.
Risks
Inflation in commodities (crude/resin up 30-50%), media fragmentation, and West Asia conflict impacting supply chain costs.
Last quarter's promises, checked
Delivered
- Guided 9-month sales Rs 3374cr → delivered FY26 Rs 4300cr (= BEAT)
- Guided net margin improvement ~60bps → delivered structural margin up 100bps (= BEAT)
- Guided productivity savings Rs 93cr → delivered Rs 86cr in FY26 (= BEAT)
Partly delivered
- Guided rural demand recovery → delivered muted sales and rural softening (= PARTIAL)
Missed
- Guided 3% sales growth momentum → delivered flat YoY sales (= MISS)
Earnings Call filed with BSE, NSE: PGHH. Summary written with AI assistance from the document.
Procter & Gamble Hygiene & Healthcare Ltd: key numbers
- Share price
- ₹7,202.50
- Market cap
- ₹23,380 Cr
- Revenue (annual)
- ₹4,290 Cr
- Net profit (annual)
- ₹856.5 Cr
- P/E (TTM)
- 29.6×Sector 41.3×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Hygiene & Healthcare Ltd
All →Procter & Gamble Hygiene & Healthcare Other Announcement
Procter & Gamble Hygiene and Health Care Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, with the exchange.
Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene & Healthcare Management Change
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
Procter & Gamble Hygiene & Healthcare Price Movement Clarification
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
Procter & Gamble Hygiene & Healthcare Management Change
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene & Healthcare Annual General Meeting
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.